Back to Companies
Royalty Pharma plc
RPRXNasdaqCIK: 0001802768
Over the 50 most recent insider filings, Royalty Pharma plc (RPRX) has seen activity from 14 distinct insiders — all of them on the sell side. The activity is heavily weighted toward selling: $0 bought versus $76.5M sold, net sales of $76.5M. Coyne Terrance P. (EVP & CFO) is the most active by dollar volume, and the single largest transaction was $10.4M by Coyne Terrance P.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$76.6M
Purchases
$0
Sales
$76.5M
Unique Insiders
14
Recent Insider Trades
50 loaded
| Aug 17 | RPRX Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Sell | $645.6K |
| Aug 7 | RPRX Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board, Director | Grant | $0 |
| Aug 7 | RPRX Royalty Pharma plc | Hite Christopher | EVP & Chairman, Partnering | Grant | $0 |
| Aug 7 | RPRX Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Grant | $0 |
| Aug 7 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Grant | $0 |
| Jul 2 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Sell | $508.5K |
| Jun 30 | RPRX Royalty Pharma plc | Bassler Bonnie L | Director | Grant | $37.5K |
| Jul 2 | RPRX Royalty Pharma plc | Hite Christopher | EVP & Chairman, Partnering | Sell | $7.3M |
| Jun 25 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Sell | $502.1K |
| Jun 25 | RPRX Royalty Pharma plc | Hite Christopher | EVP & Chairman, Partnering | Sell | $8.2M |
| Jun 8 | RPRX Royalty Pharma plc | LOVE TED W | Director | Grant | $0 |
| Jun 8 | RPRX Royalty Pharma plc | Norden Gregory | Director | Grant | $0 |
| Jun 8 | RPRX Royalty Pharma plc | Bassler Bonnie L | Director | Grant | $0 |
| Jun 8 | RPRX Royalty Pharma plc | WEATHERMAN ELIZABETH H | Director | Grant | $0 |
| Jun 8 | RPRX Royalty Pharma plc | Engelbert Catherine M. | Director | Grant | $0 |
| Jun 8 | RPRX Royalty Pharma plc | Ho Carole | Director | Grant | $0 |
| Jun 8 | RPRX Royalty Pharma plc | HODGSON DAVID C | Director | Grant | $0 |
| Jun 8 | RPRX Royalty Pharma plc | Coric Vlad | Director | Grant | $0 |
| May 28 | RPRX Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Sell | $3.5M |
| May 21 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Sell | $721.8K |
| May 15 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Sell | $726.1K |
| May 8 | RPRX Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board, Director | Grant | $0 |
| May 8 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Grant | $0 |
| Apr 30 | RPRX Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Sell | $1.7M |
| Apr 2 | RPRX Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Sell | $1.7M |
| Mar 25 | RPRX Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Sell | $1.6M |
| Mar 4 | RPRX Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Sell | $1.6M |
| Feb 4 | RPRX Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Sell | $10.4M |
| Feb 2 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Sell | $821.8K |
| Jan 26 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Sell | $805.1K |
| Jan 23 | RPRX Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Sell | $2.7M |
| Jan 20 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Sell | $790.3K |
| Jan 13 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Sell | $815.6K |
| Jan 6 | RPRX Royalty Pharma plc | McGivern Arthur Richard | EVP, Investments & GC | Other | $0 |
| Dec 29 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Sell | $786.4K |
| Dec 22 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Sell | $767.6K |
| Dec 19 | RPRX Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Sell | $4.2M |
| Dec 17 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Sell | $766.4K |
| Dec 17 | RPRX Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Sell | $2.7M |
| Dec 9 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Sell | $1.6M |
| Dec 5 | RPRX Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Sell | $4.4M |
| Dec 3 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Sell | $1.7M |
| Dec 3 | RPRX Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Sell | $2.8M |
| Nov 26 | RPRX Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Sell | $2.7M |
| Nov 21 | RPRX Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Sell | $5.2M |
| Nov 19 | RPRX Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Sell | $2.7M |
| Nov 7 | RPRX Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Grant | $0 |
| Nov 7 | RPRX Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board, Director | Grant | $0 |
| Sep 30 | RPRX Royalty Pharma plc | Bassler Bonnie L | Director | Grant | $37.5K |
| Aug 11 | RPRX Royalty Pharma plc | Norden Gregory | Director | Sell | $1.2M |
50 filings+